| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.001 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -9.3e-05 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -4.6e-05 | 1 |